Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
Single-dose vials and multiple-dose vials of CARBOCAINE may be sterilized by autoclaving at 15-pound pressure, 121 °C (250 °F) for 15 minutes. Solutions of CARBOCAINE may be reautoclaved when necessary.
CARBOCAINE (mepivacaine hydrochloride) injection is a clear, colorless solution. Do not administer solutions which are discolored or which contain particulate matter.
| Unit of Sale and Product Description | Concentration |
|---|---|
1% Contains 10 mg mepivacaine hydrochloride per mL | |
NDC 0409-1036-30 Carton of 1 30 mL Single-Dose Vial | 300 mg/30 mL (10 mg/mL) |
NDC 0409-1038-50 Carton of 1 50 mL Multiple-Dose Vial | 500 mg/50 mL (10 mg/mL) |
1.5% Contains 15 mg mepivacaine hydrochloride per mL | |
NDC 0409-1041-30 Carton of 1 30 mL Single-Dose Vial | 450 mg/30 mL (15 mg/mL) |
2% Contains 20 mg mepivacaine hydrochloride per mL | |
NDC 0409-1067-20 Carton of 1 20 mL Single-Dose Vial | 400 mg/20 mL (20 mg/mL) |
NDC 0409-2047-50 Carton of 1 50 mL Multiple-Dose Vial | 1,000 mg/50 mL (20 mg/mL) |
For single-dose vials: Discard unused portion.
Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
Single-dose vials and multiple-dose vials of CARBOCAINE may be sterilized by autoclaving at 15-pound pressure, 121 °C (250 °F) for 15 minutes. Solutions of CARBOCAINE may be reautoclaved when necessary.
CARBOCAINE (mepivacaine hydrochloride) injection is a clear, colorless solution. Do not administer solutions which are discolored or which contain particulate matter.
| Unit of Sale and Product Description | Concentration |
|---|---|
1% Contains 10 mg mepivacaine hydrochloride per mL | |
NDC 0409-1036-30 Carton of 1 30 mL Single-Dose Vial | 300 mg/30 mL (10 mg/mL) |
NDC 0409-1038-50 Carton of 1 50 mL Multiple-Dose Vial | 500 mg/50 mL (10 mg/mL) |
1.5% Contains 15 mg mepivacaine hydrochloride per mL | |
NDC 0409-1041-30 Carton of 1 30 mL Single-Dose Vial | 450 mg/30 mL (15 mg/mL) |
2% Contains 20 mg mepivacaine hydrochloride per mL | |
NDC 0409-1067-20 Carton of 1 20 mL Single-Dose Vial | 400 mg/20 mL (20 mg/mL) |
NDC 0409-2047-50 Carton of 1 50 mL Multiple-Dose Vial | 1,000 mg/50 mL (20 mg/mL) |
For single-dose vials: Discard unused portion.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.